PME pro medicus limited

NPAT in 2016 was $6.4m but that included $3.8m depreciation...

  1. 1,252 Posts.
    lightbulb Created with Sketch. 19
    NPAT in 2016 was $6.4m but that included $3.8m depreciation versus $5.8m investing cash outflows which are mostly for software development. I prefer to include these in my profit figure given they are a cost of doing business for software companies. Therefore, normalised profit for 2016 was <$5m in line with FCF.

    For forward PE to be under 30 you are saying that FCF this year will be >$15m - I would be very surprised.

    Even if you are right, I'd still question the logic of buying back stock at 30x earnings. Then again, they have a better idea of the value of the business than me but it would have to be a business of extremely rare quality for this to be justified.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$317.34
Change
-0.350(0.11%)
Mkt cap ! $33.15B
Open High Low Value Volume
$318.00 $320.18 $313.61 $58.36M 184.4K

Buyers (Bids)

No. Vol. Price($)
1 490 $317.00
 

Sellers (Offers)

Price($) Vol. No.
$317.34 226 2
View Market Depth
Last trade - 16.10pm 11/07/2025 (20 minute delay) ?
PME (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.